Novartis Ag (NVS) Dividend Coverage Ratio (QoQ) (2009 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) Dividend Coverage Ratio (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.80% |
| Mar 31, 2026 | 44.30% |
| Jun 30, 2025 | -66.61% |
| Mar 31, 2025 | 35.80% |
| Jun 30, 2024 | -95.88% |
| Mar 31, 2021 | -145.97% |
| Mar 31, 2020 | 76.86% |
| Mar 31, 2017 | 56.54% |
| Mar 31, 2016 | 49.84% |
| Mar 31, 2015 | -141.76% |
| Mar 31, 2014 | 50.61% |
| Jun 30, 2013 | 107,680.12% |
| Mar 31, 2013 | 51.60% |
| Jun 30, 2012 | -35,331.21% |
| Mar 31, 2012 | 64.45% |
| Dec 31, 2011 | 99.61% |
| Sep 30, 2011 | -57.10% |
| Jun 30, 2011 | -32,242.16% |
| Mar 31, 2011 | 60.29% |
| Jun 30, 2010 | -20,901.10% |